Skip to main content
HairCited

Platelet-rich plasma in the treatment of alopecia areata after COVID-19 vaccination.

Hsiang-Chiun Teng, Hsin-Hsu Chen
Case Report Clinical case reports 2023 8 sitasi
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D37192849'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Jenis Studi
Case Reports
Populasi
None
Durasi
4 weeks
Intervensi
Platelet-rich plasma in the treatment of alopecia areata after COVID-19 vaccination. None
Pembanding
None
Luaran Utama
hair growth/density
Arah Efek
Neutral
Risiko Bias
High

Abstract

KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID-19 vaccination. Platelet-rich plasma (PRP) has an outstanding anti-inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34-year-old female with no systemic illness presented with non-scarring hair loss after the second COVID-19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double-spin PRP therapy. Her hair recovered completely after six courses of PRP treatment.

TL;DR

Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids.

Used In Evidence Reviews

Similar Papers